1-5 of 5
Jason T. Romancik
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes for CART as 2L vs 3L vs 4L or Beyond in Aggressive B-cell Lymphoma: Real World Evidence from the ABC Consortium

Open Access
John Seng Wang, Brandon Lee Ellsworth, Megan Melody, Narendranath Epperla, Deborah M Stephens, Jason T. Romancik, Matthew J. Cortese, Rahul S Bhansali, Tamara K Moyo, Vaishalee P Kenkre, Thomas A Ollila, Brian T Hess, Lindsey A. Fitzgerald, Geoffrey Shouse, Matthew J. Matasar, Megan M. Herr, James A Davis, Christy Jesme, Ari Pelcovits, Jonathan Moreira, Adam Yuh Lin, Shuo Ma, Jane N Winter, Alexey V Danilov, Nirav N Shah, Stefan K. Barta, Jonathon B Cohen, Leo I. Gordon, Natalie S. Grover, Reem Karmali
Journal: Blood Advances
Blood Adv bloodadvances.2025017120.
https://doi.org/10.1182/bloodadvances.2025017120
Published: 2025
Includes: Supplemental data
Journal Articles

Outcomes of Bispecific Antibodies After CAR T-Cell Failure for Large B-cell Lymphoma- Results from the ABC Consortium

Open Access
Megan Melody, Natalie S. Grover, Stephanie Franco, Jason T. Romancik, Matthew J. Cortese, Tamara K Moyo, Rahul S Bhansali, Thomas A Ollila, Vaishalee P Kenkre, Lindsey A. Fitzgerald, Brian T Hess, Matthew J. Matasar, Geoffrey Shouse, Kaitlin Annunzio, Megan M. Herr, James A Davis, Christy Jesme, Ari Pelcovits, Jonathan Moreira, Shuo Ma, Jane N Winter, Adam Yuh Lin, Alexey V Danilov, Ishan Roy, Stefan K. Barta, Leo I. Gordon, Deborah M Stephens, Jonathon B Cohen, Narendranath Epperla, Reem Karmali
Journal: Blood Advances
Blood Adv bloodadvances.2025016968.
https://doi.org/10.1182/bloodadvances.2025016968
Published: 2025
Journal Articles

Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCL

Free
Arushi Khurana, Raphael Mwangi, Loretta J. Nastoupil, Patrick M. Reagan, Umar Farooq, Jason T. Romancik, Timothy J. McDonnell, Shaun M. Riska, lzidore S. Lossos, Brad S. Kahl, Peter Martin, Thomas E. Witzig, James R. Cerhan, Christopher R. Flowers, Grzegorz S. Nowakowski, Matthew J. Maurer
Journal: Blood Advances
Blood Adv (2024) 8 (16): 4414–4422.
https://doi.org/10.1182/bloodadvances.2024012838
Published: 2024
Includes: Supplemental data
Journal Articles

Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions

Free
Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G. Karrison, Rachel Treitman, Manali K. Kamdar, Bradley M. Haverkos, James Godfrey, Melissa A. Babcook, Timothy J. Voorhees, Sophie Carlson, Daria Gaut, Caspian Oliai, Jason T. Romancik, Allison M. Winter, Brian T. Hill, Radhika Bansal, Jose C. Villasboas Bisneto, Imran A. Nizamuddin, Reem Karmali, Lindsey A. Fitzgerald, Deborah M. Stephens, Priyanka A. Pophali, Asaad Trabolsi, Jonathan H. Schatz, Marie Hu, Veronika Bachanova, Michael J. Slade, Nathan Singh, Nausheen Ahmed, Joseph P. McGuirk, Michael R. Bishop, Peter A. Riedell, Justin Kline
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4528–4538.
https://doi.org/10.1182/bloodadvances.2023010016
Published: 2023
Includes: Supplemental data
Journal Articles

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma

Free
Yazeed Sawalha, Subir Goyal, Jeffrey M. Switchenko, Jason T. Romancik, Manali Kamdar, I. Brian Greenwell, Brian T. Hess, Krista M. Isaac, Craig A. Portell, Alex Mejia Garcia, Scott Goldsmith, Natalie S. Grover, Peter A. Riedell, Reem Karmali, Madelyn Burkart, Michael Buege, Othman Akhtar, Pallawi Torka, Anita Kumar, Brian T. Hill, Brad S. Kahl, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2023) 7 (13): 2983–2993.
https://doi.org/10.1182/bloodadvances.2022008916
Published: 2023
Includes: Supplemental data